Stifel initiates coverage of Whitehawk Therapeutics with Buy rating and $9 price target
WHWK•Stifel initiated coverage of Whitehawk Therapeutics with a Buy rating and a $9 price target.
Related News
Canada research roundup: Air Canada, Dye & Durham Limited, Onex Corporation
EWC•
Coty names Kara Langan general manager, U.S. consumer beauty division
COTY•
United Airlines: Jefferies cuts target price to $134 from $155
UAL•
Sadot Group buys SalesIQ software platform assets for stated US$7.45 million
SDOT•
Volkswagen Group launches “For Europe” competitiveness initiative focused on EVs, batteries, software and AI
VWAGY•